CASE REPORT ON SJOGREN’S SYNDROME AND CANNABIDIOL

I recently saw a 53 y/o woman with Mixed Connective Tissue Disease, (MCTD). She had typical arthritis, as well as a very dry mouth, which is the hallmark sign for Sjogren’s disease.

I would think that using fairly low doses of CBD oral-buccally would work well. For this patient, as she had so much pain, dermal abnormalities, severe chondromalacia in addition to her Sjogren’s that I elected to treat her orally with CBD capsules.

Her improvement was first a change in her mood followed a few days later with near resolution of her dry mouth.

In addition, her blurry vision has resolved, which was probably uveitis, but she will be seeing her ophthalmologist soon to see if her retina is less swollen.

I have been very pleased with the results in patients with MCTD

Author
Allan Frankel, MD Dr Allan Frankel is one of the few physicians in the US who truly understands Cannabis as a medicine. All treatments suggested have been well studied. Every patient seen by Dr Frankel is given a personally created Treatment Plan created with the patient's specific issues defined. Plant medicine requires "tuning" of the dosing. Dr Frankel works with his patients thru a messaging portal. The use of this portal, allows quick and simple follow up contact with Dr Frankel. Patients are not charged for these messages, as this is how Dr Frankel has learned what he has learned. Follow up appointments in person or by phone/video are also available when needed

You Might Also Enjoy...

Rationing Health Care

With COVID, we have never been more aware of critical shortages of masks, ventilators, hospital beds, etc., all leading to rationing. In this BLOG, Dr Frankel, examines how rationing in our medical care is a much bigger problem than just face masks.

Cannabis May Prevent COVID-19 Infections

Early studies in both Israel and Canada show findings consistent with CBD's effect on COVID-19's ability to take hold in the lungs or the gastrointestinal tract. If the receptors are reduced, the viral infection and pulmonary toxicity should be reduced.